Answers are grounded in this paper and cite their sources.
In vitro experimental study demonstrates efficient niacin production from 3-cyanopyridine using immobilized recombinant bacteria, suggesting viable industrial biocatalysis.
Niacin (vitamin B3) is a high-value chemical widely used in the pharmaceutical and food industries. In this study, a recombinant Escherichia coli strain expressing nitrilase from Pseudomonas putida CGMCC3830 was evaluated for the whole-cell biotransformation of high-concentration 3-cyanopyridine to niacin. Molecular docking predicted important substrate-interacting residues, including T135, K131, F202, and W166. Under optimized conditions (160 g/L wet cells, pH 8.5), free whole cells completely hydrolyzed 3.0 M 3-cyanopyridine within 8 h. To enhance operational stability, the cells were immobilized in sodium alginate beads containing green zeolite. The resulting catalyst achieved complete conversion of 1.4 M 3-cyanopyridine within 4 h and maintained 96.5% conversion after six cycles. These findings demonstrate the potential of this system for future industrial applications.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: